Steve Paul, Karuna Therapeutics CEO

Karuna looks to build on pos­i­tive schiz­o­phre­nia da­ta with one of the biggest pub­lic rais­es this year

Rid­ing high on pos­i­tive schiz­o­phre­nia da­ta it be­lieves has the po­ten­tial to re­shape the en­tire field, Karuna Ther­a­peu­tics put out word late Mon­day that it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.